As one of the most genomic amplification gene in HCC, VEGFA has been recognized as a crucial role in HCC progression, and antiangiogenic agents have been approved for advanced-stage HCC [1, 24]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.